Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
GM ended Thursday’s session up 1.86%, according to a market recap, as investors continued to weigh recent momentum in the automaker ahead of upcoming updates.
THE APEX TIMES
THE APEX TIMES
A recent market commentary suggests pay-by-bank could capture customers who were not fully won by mobile wallets, even as it remains unclear how quickly card-network economics would be affected.
THE APEX TIMES
After its Covid-era vaccine surge, Moderna is again positioning its platform for future outbreaks, with a market report highlighting progress in Ebola vaccine development.
THE APEX TIMES
The insurer’s quarterly cash dividend rises from $2.21 to $2.32, payable June 23 to shareholders of record June 15, continuing a long-running payout schedule.
THE APEX TIMES
The retailer said customer complaints of discoloration prompted testing that detected Burkholderia cepacia complex and Burkholderia gladioli in select fragrance-free and cucumber-scented baby wipe products. Target urged shoppers to stop using the wipes and return them for a full refund.
THE APEX TIMES
The payments network said it will test Brale’s U.S.-dollar-backed stablecoin, SBC, using the Canton Network in a proof-of-concept aimed at speeding up settlement while limiting visibility of sensitive transaction data.
THE APEX TIMES
After a $19.5 billion noncash EV-related charge, Ford is trying to monetize retired EV know-how through a new battery energy storage business. A fresh framework deal with EDF has fueled optimism, even as Ford’s core vehicle sales remain under pressure.
THE APEX TIMES
A recent pullback in Coca-Cola’s stock reignited a fair-value argument, pitting an “earnings-based” view that suggests shares trade above value against a discounted-cash-flow model that implies they could be undervalued. The dispute comes as the company posts solid first-quarter momentum and reiterates 2026 growth guidance, while factoring in the expected sale of Coca-Cola Beverages Africa.
THE APEX TIMES
Moderna’s stock rose in the afternoon after the company and Merck presented long-term results for intismeran autogene, a personalized mRNA-based cancer vaccine, in high-risk melanoma.
